Design of ciprofloxacin-loaded nano-and microcomposite particles for dry powder inhaler formulations: preparation, in vitro characterisation, and antimicrobial efficacy

References

• Adi, H., et al., 2010. Controlled release antibiotics for dry powder lung delivery. Drug development and industrial pharmacy, 36 (1), 119–126.
   PubMed Web of Science ®Google Scholar
• Alfagih, I., et al., 2015. Pulmonary delivery of proteins using nanocomposite microcarriers. Journal of pharmaceutical sciences, 104 (12), 4386–4398.
   PubMed Web of Science ®Google Scholar
• Bilensoy, E., et al., 2009. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors. International journal of pharmaceutics, 371 (1–2), 170–176.
   PubMed Web of Science ®Google Scholar
• Blanco, M.D. and Alonso, M.J., 1997. Development and characterization of protein loaded poly(lactide-co-glycolide) nanospheres. European journal of pharmaceutics and biopharmaceutics, 43 (3), 287–294.
   Web of Science ®Google Scholar
• Bosquillon, C., et al., 2001. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. Journal of controlled release, 70 (3), 329–339.
   PubMed Web of Science ®Google Scholar
• Budhian, A., Siegel, S.J., and Winey, K.I., 2008. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. International journal of pharmaceutics, 346 (1–2), 151–159.
   PubMed Web of Science ®Google Scholar
• Chanburee, S. and Tiyaboonchai, W., 2017. Mucoadhesive nanostructured lipid carriers (NLCs) as potential carriers for improving oral delivery of curcumin. Drug development and industrial pharmacy, 43 (3), 432–440.
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing. Twenty-third Informational Supplement. M100-S23. CLSI, 34 (1), Wayne, PA.
   Google Scholar
• Cooper, D.L. and Harirforoosh, S., 2014. Effect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticles. PLoS One, 9 (12), e113558
   PubMed Web of Science ®Google Scholar
• Devrim, B. and Bozkır, A., 2013. Preparation and evaluation of double-walled microparticles prepared with a modified water-in-oil-in-oil-in-water (w1/o/o/w3) method. Journal of microencapsulation, 30 (8), 741–754.
   PubMed Web of Science ®Google Scholar
• Devrim, B. and Bozkır, A., 2014. Preparation and in vitro evaluation of surface-modified poly (lactide-co-glycolide) microparticles as biodegradable drug carriers for pulmonary peptide and protein delivery. Journal of microencapsulation, 31 (4), 355–362.
   PubMed Web of Science ®Google Scholar
• Devrim, B., Bozkır, A., and Canefe, K., 2011a. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: I. Effects of some formulation parameters on microparticle characteristics. Journal of microencapsulation, 28 (6), 582–594.
   PubMed Web of Science ®Google Scholar
• Devrim, B., Bozkır, A., and Canefe, K., 2011b. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations. Drug development and industrial pharmacy, 37 (11), 1376–1386.
   PubMed Web of Science ®Google Scholar
• Devrim, B., et al., 2016. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation. Drug development and industrial pharmacy, 42 (11), 1865–1876.
   PubMed Web of Science ®Google Scholar
• Dillen, K., et al., 2006. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. International journal of pharmaceutics, 314 (1), 72–82.
   PubMed Web of Science ®Google Scholar
• Elhissi, A., 2017. Liposomes for pulmonary drug delivery: the role of formulation and inhalation device design. Current pharmaceutical design, 23 (3), 362–372.
   PubMed Web of Science ®Google Scholar
• Elkheshen, S.A., et al., 2013. Formulation of ciprofloxacin hydrochloride loaded biodegradable nanoparticles: optimization of the formulation variables. Journal of pharmaceutical research and opinion, 3 (11), 72–81.
   Google Scholar
• Eskandar, F., Lejeune, M., and Edge, S., 2011. Low powder mass filling of dry powder inhalation formulations. Drug development and industrial pharmacy, 37 (1), 24–32.
   PubMed Web of Science ®Google Scholar
• Fei, X., et al., 2016. The fluorescent interactions between amphiphilic chitosan derivatives and water-soluble quantum dots. Spectrochimica acta part A: Molecular and biomolecular spectroscopy, 152, 343–351.
   PubMed Web of Science ®Google Scholar
• Ghasemian, E., et al., 2016. Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics. Pharmaceutical development and technology, 21 (8), 961–971.
   PubMed Web of Science ®Google Scholar
• González-Rodríguez, M.L., et al., 2007. Application of statistical experimental design to study the formulation variables influencing the coating process of lidocaine liposomes. International journal of pharmaceutics, 337 (1–2), 336–345.
   PubMed Web of Science ®Google Scholar
• Govender, T., et al., 1999. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug . Journal of controlled release, 57 (2), 171–185.
   PubMed Web of Science ®Google Scholar
• Haggag, Y., et al., 2016. Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG. International journal of pharmaceutics, 499 (1–2), 236–246.
   PubMed Web of Science ®Google Scholar
• Jain, S.P., et al., 2008. In situ ophthalmic gel of ciprofloxacin hydrochloride for once a day sustained delivery. Drug development and industrial pharmacy, 34 (4), 445–452.
   PubMed Web of Science ®Google Scholar
• Jalalipour, M., et al., 2008. Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents. International journal of pharmaceutics, 352 (1–2), 209–216.
   PubMed Web of Science ®Google Scholar
• Jensen, D.M.K., et al., 2010. Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation. Journal of controlled release, 142 (1), 138–145.
   PubMed Web of Science ®Google Scholar
• Jeong, Y.-I., et al., 2008. Ciprofloxacin-encapsulated poly(D,L-lactide-co-glycolide) nanoparticles and its antibacterial activity. International journal of pharmaceutics, 352 (1–2), 317–323.
   PubMed Web of Science ®Google Scholar
• Karimi, K., et al., 2016. Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach. Drug design, development and therapy, 10, 3331–3343.
   PubMed Web of Science ®Google Scholar
• Kawashima, Y., et al., 2000. Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharmaceutical development and technology, 5 (1), 77–85.
   PubMed Web of Science ®Google Scholar
• Kim, B.S., Kim, C.S., and Lee, K.M., 2008. The Intracellular Uptake Ability of Chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles. Archives of pharmacal research, 31 (8), 1050–1054.
   PubMed Web of Science ®Google Scholar
• Kunda, N.K., et al., 2015. Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation. Pharmaceutical research, 32 (4), 1341–1353.
   PubMed Web of Science ®Google Scholar
• Kunda, N.K., et al., 2013. Nanocarriers targeting dendritic cells for pulmonary vaccine delivery. Pharmaceutical research, 30 (2), 325–341.
   PubMed Web of Science ®Google Scholar
• Lee, D.-W., et al., 2006. Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respiratory research, 7, 1–10.
   PubMed Web of Science ®Google Scholar
• Levet, V., et al., 2016. Development of controlled-release cisplatin dry powders for inhalation against lung cancers. International journal of pharmaceutics, 515 (1–2), 209–220.
   PubMed Web of Science ®Google Scholar
• Littringer, E.M., et al., 2012. Spray dried mannitol carrier particles with tailored surface properties-the influence of carrier surface roughness and shape. European journal of pharmaceutics and biopharmaceutics, 82 (1), 194–204.
   PubMed Web of Science ®Google Scholar
• Malaekeh-Nikouei, B., Tabassi, S.A.S., and Jaafari, M.R., 2008. Preparation, characterization, and mucoadhesive properties of chitosan-coated microspheres encapsulated with cyclosporine A. Drug development and industrial pharmacy, 34 (5), 492–498.
   PubMed Web of Science ®Google Scholar
• McConville, J.T. and Son, Y.-J., 2008. Advancements in dry powder delivery to the lung. Drug development and industrial pharmacy, 34 (9), 948–959.
   PubMed Web of Science ®Google Scholar
• Moazeni, E., et al., 2010. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery. Journal of microencapsulation, 27 (7), 618–627.
   PubMed Web of Science ®Google Scholar
• Mustafa, S., Devi, V.K., and Pai, R.S., 2017. Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles. Drug delivery and translational research, 7 (1), 27–36.
   PubMed Web of Science ®Google Scholar
• Ong, H.X., et al., 2014. Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases. The AAPS journal, 16 (2), 269–280.
   PubMed Web of Science ®Google Scholar
• Osman, R., et al., 2013. Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity. International journal of pharmaceutics, 449 (1–2), 44–58.
   PubMed Web of Science ®Google Scholar
• Palamoor, M. and Jablonski, M.M., 2014. Comparative study on diffusion and evaporation emulsion methods used to load hydrophilic drugs in poly(ortho ester) nanoparticle emulsions. Powder technology, 253, 53–62.
   Web of Science ®Google Scholar
• Pandita, D., Kumar, S., and Lather, V., 2015. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives. Drug discovery today, 20 (1), 95–104.
   PubMed Web of Science ®Google Scholar
• Park, M.H., et al., 2014. The effect of Eudragit type on BSA-loaded PLGA nanoparticles. Journal of pharmaceutical investigation, 44 (5), 339–349.
   Google Scholar
• Patil, A.S., et al., 2013. Influence of organic solvents on nanoparticles loaded with gatifloxacin. Universal journal of pharmacy, 02 (02), 95–101.
   Google Scholar
• Przybyslawska, M., AmelAn, A., and Winnicka, K., 2013. Preparation of ciprofloxacin encapsulated poly-ε-caprolactone microcapsules by the solvent evaporation technique. e-Polymers, 30, 1–11.
   Google Scholar
• Sahoo, S., Chakraborti, C.K., and Mishra, S.C., 2012. Qualitative analysis of a ciprofloxacin/HPMC mucoadhesive suspension. Journal of advanced pharmaceutical technology & research, 2 (3), 195–576.
   Google Scholar
• Seville, P.C., Li, H., and Learoyd, T.P., 2007. Spray-dried powders for pulmonary drug delivery. Critical reviews in therapeutic drug carrier systems, 24 (4), 307–360.
   PubMed Web of Science ®Google Scholar
• Smith, D.J., et al., 2001. Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines. Infection and immunity, 69 (8), 4767–4773.
   PubMed Web of Science ®Google Scholar
• Song, X., et al., 2012. β-methasone-containing biodegradable poly(lactide-coglycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release. Pharmaceutical development and technology, 18 (5): 1220–1229.
   PubMed Web of Science ®Google Scholar
• Soppimath, K.S., et al., 2001. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of controlled release , 70 (1–2), 1–20.
   PubMed Web of Science ®Google Scholar
• Tahara, K., Yamamoto, H., and Kawashima, Y., 2010. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery. European journal of pharmaceutics and biopharmaceutics, 75 (2), 218–224.
   PubMed Web of Science ®Google Scholar
• Taki, M., et al., 2016. Fabrication of nanocomposite particles using a two-solution mixing-type spray nozzle for use in an inhaled curcumin formulation. International journal of pharmaceutics, 511 (1), 104–110.
   PubMed Web of Science ®Google Scholar
• Tena, A.F. and Clara, P.C., 2012. Deposition of inhaled particles in the lungs. Archivos de bronconeumología, 48 (7), 240–246.
   PubMed Web of Science ®Google Scholar
• Türk, C.T., Hasçiçek, C., and Gönül, N., 2009. Evaluation of drug-polymer interaction in polymeric microspheres containing diltiazem hydrochloride. Journal of thermal analysis and calorimetry, 95 (3), 865–869.
   Web of Science ®Google Scholar
• Vila, A., et al., 2002. Design of biodegradable particles for protein delivery. Journal of controlled release, 78 (1–3), 15–24.
   PubMed Web of Science ®Google Scholar
• Wang, Z., et al., 2016. Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension. International journal of pharmaceutics, 512 (1), 305–313.
   PubMed Web of Science ®Google Scholar
• Wang, Z. and Meenach, S.A., 2016. Synthesis and characterization of nanocomposite microparticles (nCmP) for the treatment of cystic fibrosis-related infections. Pharmaceutical research, 33 (8), 1862–1872.
   PubMed Web of Science ®Google Scholar
• Watts, A.B., et al., 2010. Characterization and pharmacokinetic analysis of tacrolimus dispersion for nebulization in a lung transplanted rodent model. International journal of pharmaceutics, 384 (1–2), 46–52.
   PubMed Web of Science ®Google Scholar
• Yhee, J.Y., Im, J., and Nho, R.S., 2016. Advanced therapeutic strategies for chronic lung disease using nanoparticle-based drug delivery. Journal of clinical medicine, 5 (9), 82. doi:10.3390/jcm5090082.
   PubMed Web of Science ®Google Scholar
• Yüksel, N., Karataş, A., and Baykara, T., 2003. Comparative evaluation of granules made with different binders by a fluidized bed method. Drug development and industrial pharmacy, 29 (4), 387–395.
   PubMed Web of Science ®Google Scholar
• Zeng, P., et al., 2011. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. International journal of pharmaceutics, 415 (1–2), 259–266.
   PubMed Web of Science ®Google Scholar
• Zhang, J., et al., 2011. Formation, characterization, and fate of inhaled drug nanoparticles. Advanced drug delivery reviews, 63 (6), 441–455.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2014. Fabrication, characterization and antimicrobial activities of thymol-loaded zein nanoparticles stabilized by sodium caseinate-chitosan hydrochloride double layers. Food chemistry, 142, 269–275.
   PubMed Web of Science ®Google Scholar